Загрузка...
Systemic therapy for hepatocellular carcinoma
Optimal treatment of hepatocellular carcinoma (HCC) is clinically challenging. Systemic treatment for advanced HCC was limited until the approval of sorafenib. This discovery resulted in the advent of many clinical trials. An ongoing Phase III trial is examining the benefit of adjuvant sorafenib. Ut...
Сохранить в:
| Опубликовано в: : | Hepat Oncol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Future Medicine Ltd
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6114012/ https://ncbi.nlm.nih.gov/pubmed/30190939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.13.10 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|